First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer

Gianluca Tedaldi, Rita Danesi, Valentina Zampiga, Michela Tebaldi, Lucia Bedei, Wainer Zoli, Dino Amadori, Fabio Falcini, Daniele Calistri

Research output: Contribution to journalArticle

Abstract

Background: CHEK2 is a multi-cancer susceptibility gene whose common germline mutations are known to contribute to the risk of developing breast and prostate cancer.Case presentation: Here, we describe an Italian family with a high number of cases of breast cancer and other types of tumour subjected to the MLPA test to verify the presence of BRCA1, BRCA2 and CHEK2 deletions and duplications. We identified a new 23-kb duplication in the CHEK2 gene extending from intron 5 to 13 that was associated with breast cancer in the family. The presence and localisation of the alteration was confirmed by a second analysis by Next-Generation Sequencing.Conclusions: This finding suggests that CHEK2 mutations are heterogeneous and that techniques other than sequencing, such as MLPA, are needed to identify CHEK2 mutations. It also indicates that CHEK2 rare variants, such as duplications, can confer a high susceptibility to cancer development and should thus be studied in depth as most of our knowledge of CHEK2 concerns common mutations.

Original languageEnglish
Article number478
JournalBMC Cancer
Volume14
Issue number1
DOIs
Publication statusPublished - Jul 1 2014

Keywords

  • Breast cancer
  • CHEK2
  • Duplication
  • Hereditary cancer
  • MLPA
  • Next-generation sequencing

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics
  • Medicine(all)

Fingerprint Dive into the research topics of 'First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer'. Together they form a unique fingerprint.

Cite this